2011 annual financial data
Innate Pharma 2011 Operating margin
Direct answer
Operating margin was -64.48%.
Operating income was -7,570,000 EUR and net income was -6,980,000 EUR.
Operating cash flow was Not available.
Get free Innate Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 11,740,000 EUR
- Operating income
- -7,570,000 EUR
- Net income
- -6,980,000 EUR
- Operating cash flow
- Not available